Rozalina Dimitrova
Overview
Explore the profile of Rozalina Dimitrova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
1770
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gormley M, Fehlings D, Kim H, Bonikowski M, Banach M, Gul F, et al.
J Child Neurol
. 2024 Dec;
:8830738241288431.
PMID: 39716821
Aim: To evaluate the efficacy and safety of onabotulinumtoxinA for treating upper and lower limb spasticity among pediatric patients in 2 open-label extension trials. Methods: Patients aged <18 years received...
2.
Gormley M, Chambers H, Kim H, Leon J, Dimitrova R, Brin M
Medicine (Baltimore)
. 2023 Jul;
102(S1):e32363.
PMID: 37499087
Spasticity is a velocity-dependent increase in muscle tone that has a negative effect on quality of life and hinders the ability of others to provide care. In children, most cases...
3.
Esquenazi A, Jost W, Turkel C, Wein T, Dimitrova R
Medicine (Baltimore)
. 2023 Jul;
102(S1):e32376.
PMID: 37499086
Upper and lower limb spasticity (ULS, LLS) often occur following a stroke or in patients with other neurological disorders, leading to difficulties in mobility and daily living and decreased quality...
4.
Dimitrova R, Kim H, Meilahn J, Chambers H, Racette B, Bonikowski M, et al.
NeuroRehabilitation
. 2021 Dec;
50(1):33-46.
PMID: 34957954
Background: Spasticity is common in cerebral palsy and can result in pain and diminished health-related quality of life. Objective: To evaluate the safety and efficacy of onabotulinumtoxinA for lower limb...
5.
Dimitrova R, McCusker E, Gormley M, Fehlings D, Alter K, Greaves S, et al.
NeuroRehabilitation
. 2021 Aug;
49(3):469-479.
PMID: 34334431
Background: This is the first large study of onabotulinumtoxinA as treatment for pediatric upper limb spasticity. Objective: Evaluate efficacy and safety of a single treatment with onabotulinumtoxinA plus occupational therapy...
6.
Patel A, Ward A, Geis C, Jost W, Liu C, Dimitrova R
J Neural Transm (Vienna)
. 2020 Oct;
127(12):1619-1629.
PMID: 33106968
The aim of this study in patients with post-stroke lower limb spasticity (PSLLS) was to evaluate the relationship between time of onabotulinumtoxinA treatment relative to stroke and efficacy outcomes. This...
7.
Ayyoub Z, Brashear A, Banach M, Schoene R, Stringer W, Boodhoo T, et al.
Toxins (Basel)
. 2020 Oct;
12(10).
PMID: 33086749
Two randomized, placebo-controlled studies evaluated the pulmonary function safety of onabotulinumtoxinA (onabotA) for treatment of upper and/or lower limb spasticity. Patients with stable baseline respiratory status received one or two...
8.
Dimitrova R, James L, Liu C, Orejudos A, Yushmanova I, Brin M
CNS Drugs
. 2020 Mar;
34(4):433-445.
PMID: 32170665
Background: OnabotulinumtoxinA is approved as a treatment across multiple indications. For the treatment of spasticity, onabotulinumtoxinA is injected directly into affected muscles. Intramuscular injections may result in local bleeding and...
9.
Esquenazi A, Wein T, Ward A, Geis C, Liu C, Dimitrova R
Am J Phys Med Rehabil
. 2019 Apr;
98(5):360-368.
PMID: 31003229
Objective: The aim of the study was to identify optimal muscle selection patterns for onabotulinumtoxinA treatment of poststroke lower-limb spasticity. Design: Adults with poststroke lower-limb spasticity (ankle Modified Ashworth Scale...
10.
Wein T, Esquenazi A, Jost W, Ward A, Pan G, Dimitrova R
PM R
. 2018 Jan;
10(7):693-703.
PMID: 29330071
Background: Poststroke distal lower limb spasticity impairs mobility, limiting activities of daily living and requiring additional caregiver time. Objective: To evaluate the efficacy, safety, and sustained benefit of onabotulinumtoxinA in...